
Opinion|Videos|August 30, 2024
Strategies to Manage Type 2 Inflammation in Respiratory Diseases
Author(s)Reynold A. Panettieri Jr, MD
A key opinion leader explores therapeutic approaches targeting inflammation to alleviate symptoms in COPD and asthma patients.
Advertisement
Episodes in this series

- How do these markers influence the treatment regimen for patients with asthma or COPD?
- How do comorbidities affect the management of type 2 inflammation in asthma and COPD?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
FDA Guidance to Remove One of the Largest Barriers to Biosimilar Development
3
Boosting RSV Vaccination in Older Adults Could Save Thousands
4
Cancer Care in Transition: Navigating Breakthrough Therapies Amid Economic Strain
5


















































